← Connect Biopharma Holdings Ltd

Annual Trend FY 2012 FY 2013 FY 2014 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $0 $0 $0 — — $398k
$7.0m +1644.60%
$1.4m -79.88%
$26.0m +1761.98%
$64k -99.75%
$233k +264.06%
Cost of Revenue $759k
$15k -98.03%
— — — $301k
$5.7m +1795.23%
$1.3m -76.75%
$21.9m +1552.09%
$54k -99.75%
—
Gross Profit ($759k)
($15k) +98.03%
— — — $97k
$1.2m +1177.98%
$71k -94.27%
$4.1m +5673.97%
$10k -99.75%
—
Net Interest Income — — — — — — ($4k)
($9k) -113.90%
$4.5m +49654.86%
$2.3m -49.07%
$1.8m -20.28%
Research And Development — — — — — — — $53.0m $29.3m $37.8m $46.2m
Research and Development Expense — — — — $150.9m $81.2m $93.6m $51.9m $29.3m $37.8m $46.2m
Research and development expenses — — — ($106.4m) ($150.9m) ($518.0m) ($652.2m) ($51.9m) — — $46.2m
Selling, General and Administrative Expense $158k $4k $18k — — $1.2m $6.6m $2.8m — — $20.3m
Operating Lease, Expense — — — — — — — — $300k $500k —
Restructuring Expense $0 — — — — — — — — — —
Operating Expenses — — — — — — — $69.1m $48.5m $58.1m $66.5m
Total Operating Expenses $1.2m $19k $672k — — $5.9b $6.6m $2.8m — — $66.5m
Operating Income (Loss) — — — ($110.2m)
($197.8m) -79.39%
($631.4m) -219.29%
($805.6m) -27.58%
($62.1m) +92.29%
($22.5m) +63.83%
($58.1m) -158.66%
($66.2m) -14.05%
Interest Expense — — — — $117k $114k $144k $23k — — $23k
Interest Expense On Lease Liabilities — — — — $42k $44k $144k $23k — — $23k
Interest Income $53 $2k — — — $1k $16k $132k $4.5m $2.3m $1.8m
Interest Income Non Operating — — — — — — — $5.2m $4.5m $2.3m $1.8m
Net Non Operating Interest Income Expense — — — — — — — $5.2m $4.5m $2.3m $1.8m
Gain (loss) from operations ($1.2m) $92k — — — — — — — — —
Gain on sale of marketable securities $198k $24k — — — — — — — — —
Other Income — — — $2.8m $7.0m $3.0m $924k $1.6m — — —
Income from Equity Method Investments $0 — — — — — — — — — —
Other Nonoperating Income (Expense) — — — — — — — $1.8m $2.6m $523k —
Non-Operating Income (Expense) $111k ($5k) — — — ($70k) ($1.1m) ($292k) — — —
Other Income Expense — — — — — — — $1.8m $2.6m $523k $11k
Total other income (expense) — — — — — $1k ($301k) ($2.1m) — — —
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — — — — — — $644k $747k ($64.4m)
Pre-Tax Income — — — — — — — ($62.0m) ($15.4m) ($55.3m) ($64.4m)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — — — — — — — — ($15.4m) ($55.3m) ($64.4m)
Loss before income tax — — — ($168.6m) ($779.2m) ($1.3b) ($795.0m) ($59.4m) — — —
Income Tax Expense Continuing Operations — — — — — $266k $292k $120k — — $191k
Income tax expense — — — $0 $0 ($1.7m) ($2.0m) ($120k) — — $191k
Income Tax Expense (Benefit) — — — — — — — — $223k $197k $191k
Net loss — — — ($168.6m) ($779.2m) ($1.3b) ($797.1m) ($59.5m) — — —
NET INCOME (LOSS) FROM CONTINUING OPERATIONS ($5.8m) ($4.9m) ($64.6m)
Net Income From Continuing And Discontinued Operation ($1.0m) ($19k) $228k — — ($5.9b) ($5.8m) ($62.1m) ($15.6m) ($55.5m) ($64.6m)
Earnings Per Share, Basic ($0.11) $0.01 — — ($45.60) ($25.00) ($14.50) ($1.08) ($0.28) ($1.00) ($1.15)
Earnings Per Share, Diluted ($0.11) ($0.01) $0.01 — ($45.60) ($25.00) ($14.50) ($1.08) ($0.28) ($1.00) ($1.15)
Basic Earnings (Loss) Per Share ($0.11) $0.01 — — ($45.60) ($25.00) ($2.10) ($1.08) ($0.28) ($1.00) ($1.15)
Diluted Earnings (Loss) Per Share ($0.11) ($0.01) $0.01 — ($45.60) ($25.00) ($2.10) ($1.08) — — ($1.15)
Weighted Average Number of Shares Outstanding, Basic — — — — — — — — 55.2m 55.7m 56.0m
Weighted Average Shares Outstanding, Diluted — 149.2m 163.4m — — 152.3m — — — — —
Basic Average Shares — — — — — — — $55.1m $55.2m $55.7m $56.0m
Diluted Average Shares — — — — — — — $55.1m $55.2m $55.7m $56.0m
Weighted Average Number of Shares Outstanding, Diluted — — — — — — — — 55.2m 55.7m 56.0m
Additional Financial Items
Depreciation Right of Use Assets — — — — $481k $909k $2.0m $272k — — —
Finance Income — — — $1.1m $717k $98k $1.5m $2.7m — — —
Profit Loss Attributable To Owners Of Parent — — — — ($779.2m) ($205.0m) ($114.4m) ($59.5m) — — —
Profit Loss Before Tax — — — — ($779.2m) ($204.7m) ($114.2m) ($59.4m) — — —
Profit Loss From Operating Activities — — — — ($197.8m) ($99.0m) ($115.7m) ($62.1m) — — —
Net impairment losses — — — — — $0 ($32.8m) $0 — — —
Other (losses)/gains—net — — — $3.0m ($6.1m) ($10.0m) $12.4m $2.8m — — —
Finance income—net — — — $1.0m ($2.2m) $578k $10.6m $2.7m — — —
Fair value loss of financial instruments with preferred rights — — — ($59.4m) ($579.3m) ($674.3m) $0 $0 — — —
Owners of the Company — — — ($168.6m) ($779.2m) ($1.3b) ($797.1m) ($59.5m) — — —
Income from Continuing Operations — — — — — ($5.9b) ($5.4m) ($2.8m) — — —
Stock loss — — — — — — ($303k) ($40k) — — —
Other Comprehensive Income (Loss) — — — — — ($5.9b) ($5.7m) ($4.9m) — — —
Basic and Diluted $9.4m $9.4m — — — $152.3m $500.6m $502.5m — — —
Professional Fees $145k $15k $37k — — — — — — — —
Foreign exchange translation gain — $1k $3k — — — — — — — —
Comprehensive income (loss) ($892k) ($18k) $231k — — — — — — — —
Labor and Employee Benefits $33k $12k — — — — — — — — —
Impairment of mineral property $100k $0 — — — — — — — — —
Foreign Currency Gain/Loss ($6k) ($8k) — — — — — — — — —
Diluted EPS — — — — — — — ($1.13) ($0.28) ($1.00) ($1.15)
Diluted NI Availto Com Stockholders — — — — — — — ($62.1m) ($15.6m) ($55.5m) ($64.6m)
Impairment Of Capital Assets — — — — — $0 — $0 — — $0
Normalized EBITDA — — — — — — — ($68.3m) ($21.8m) ($57.4m) ($65.5m)
Normalized Income — — — — — — — ($62.1m) ($15.6m) ($55.5m) ($64.6m)
Other Gand A — — — — — — — $16.1m $19.2m $20.3m —
Reconciled Depreciation — — — — — — — $720k $660k $704k $695k
Selling General And Administration — — — — — — — $16.1m $19.2m $20.3m —
Special Income Charges — — — — — $0 — $0 — — $0
Tax Effect Of Unusual Items — — — — — — — $0 $0 $0 $0
Tax Provision — — — — — — — $120k $223k $197k $191k
Tax Rate For Calcs — — — — — — $0 $0 $0 $0 $0
Administrative Expense — — — — $47.7m $19.2m $20.0m $14.5m — — —
Depreciation And Amortisation Expense — — — — $1.4m $4.1m $6.9m $988k — — —
Employee Benefits Expense — — — — $27.2m $120.2m $143.8m $15.4m — — —
Expense From Share-Based Payment Transactions With Employees — — — — $5.5m $57.9m $45.6m $3.3m — — —
Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used — — — — $30k $58k — $0 — — —
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used — — — — $45k $12k — $0 — — —
Finance Costs — — — — $2.9m $7k $21k $23k — — —
Postemployment Benefit Expense Defined Benefit Plans — — — — $971k — — — — — —
Professional Fees Expense — — — — $31.8m $69.5m $69.3m $7.5m — — —
Administrative expenses — — — ($9.7m) ($47.7m) ($122.4m) ($139.4m) ($14.5m) — — —
Finance cost — — — ($53k) ($2.9m) ($44k) ($144k) ($23k) — — —
Depreciation Expense — — — — — $5k $54k $39k — — —
TOTAL COMPREHENSIVE INCOME (LOSS) ($5.9b) ($6.9m) ($5.1m)
Total Expenses — — — — — — — $69.1m $48.5m $58.1m $66.5m

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.